EDMUNDS PHARMACOLOGY FOR THE
PRIMARY PROVIDER EXAM SCRIPT FINAL
PAPER 2026 COMPLETE QUESTIONS AND
ANSWERS
◉ 6. A thin 52-year-old woman who has recently had a hysterectomy
tells the primary care NP she is having frequent hot flashes and
vaginal dryness. A recent bone density study shows early
osteopenia. The woman's mother had CHD. She has no family history
of breast cancer. The NP should prescribe:
a.
estrogen-only HT now.
b.
estrogen-only HT in 5 years.
c.
estrogen-progesterone HT now.
d.
estrogen-progesterone HT in 5 years.
Answer: ANS: A
HT relieves symptoms of menopause and prevents osteoporosis.
When started soon after menopause, HT can reduce CHD risk. Breast
cancer risk may be decreased if HT is begun 5 years after onset of
, menopause. This woman has a higher risk of CHD and osteoporosis,
so initiating therapy now is a good option. Because she has had a
hysterectomy, estrogen-only therapy is indicated.
◉ 7. Osteopenia is diagnosed in a 55-year-old woman who has not
had a period in 15 months. She has a positive family history of breast
cancer. The primary care NP should recommend:
a.
testosterone therapy.
b.
estrogen-only therapy.
c.
nonhormonal drugs for osteoporosis.
d.
estrogen-progesterone therapy for 1 to 2 years.
Answer: ANS: C
Although estrogen slows the progression of osteoporosis, it also
increases the risk of breast cancer when initiated early in
menopause. This woman should receive a nonhormonal treatment
for osteoporosis and may receive HT in 5 years if menopausal
symptoms persist. Testosterone therapy, estrogen-only therapy, and
estrogen-progesterone therapy are not indicated.
PRIMARY PROVIDER EXAM SCRIPT FINAL
PAPER 2026 COMPLETE QUESTIONS AND
ANSWERS
◉ 6. A thin 52-year-old woman who has recently had a hysterectomy
tells the primary care NP she is having frequent hot flashes and
vaginal dryness. A recent bone density study shows early
osteopenia. The woman's mother had CHD. She has no family history
of breast cancer. The NP should prescribe:
a.
estrogen-only HT now.
b.
estrogen-only HT in 5 years.
c.
estrogen-progesterone HT now.
d.
estrogen-progesterone HT in 5 years.
Answer: ANS: A
HT relieves symptoms of menopause and prevents osteoporosis.
When started soon after menopause, HT can reduce CHD risk. Breast
cancer risk may be decreased if HT is begun 5 years after onset of
, menopause. This woman has a higher risk of CHD and osteoporosis,
so initiating therapy now is a good option. Because she has had a
hysterectomy, estrogen-only therapy is indicated.
◉ 7. Osteopenia is diagnosed in a 55-year-old woman who has not
had a period in 15 months. She has a positive family history of breast
cancer. The primary care NP should recommend:
a.
testosterone therapy.
b.
estrogen-only therapy.
c.
nonhormonal drugs for osteoporosis.
d.
estrogen-progesterone therapy for 1 to 2 years.
Answer: ANS: C
Although estrogen slows the progression of osteoporosis, it also
increases the risk of breast cancer when initiated early in
menopause. This woman should receive a nonhormonal treatment
for osteoporosis and may receive HT in 5 years if menopausal
symptoms persist. Testosterone therapy, estrogen-only therapy, and
estrogen-progesterone therapy are not indicated.
